Company Profile for Guided Therapeutics, Inc.

Guided Therapeutics, Inc. (OTCQB: GTHP) has developed a rapid and painless testing platform for the early detection of disease based on its patented biophotonic technology that utilizes light to detect disease at the cellular level.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Monday, October 26, 2020
Information
Tags: 
Health, Oncology, Medical devices, Infectious causes of cancer, Gynaecological cancer, Cervical cancer, Cancer, Clinical medicine, Health, Papillomavirus, Medical specialties
Geotags: 
United States, GEORGIA
⚠generated by AI ↴
Summary
Key Points: 
  • Guided Therapeutics, Inc. (OTCQB: GTHP) has developed a rapid and painless testing platform for the early detection of disease based on its patented biophotonic technology that utilizes light to detect disease at the cellular level.
  • The companys first product, LuViva, is a non-invasive device used to detect cervical disease instantly and at the point of care.
  • In a multi-center clinical trial, with women at risk for cervical disease, LuViva was able to detect cervical cancer up to two years earlier than conventional tests.
  • LuViva is designed to provide an objective result at the point-of-care, thereby improving the management of cervical disease: www.guidedinc.com .


Guided Therapeutics, Inc. (OTCQB: GTHP) has developed a rapid and painless testing platform for the early detection of disease based on its patented biophotonic technology that utilizes light to detect disease at the cellular level. The company’s first product, LuViva™, is a non-invasive device used to detect cervical disease instantly and at the point of care. In a multi-center clinical trial, with women at risk for cervical disease, LuViva was able to detect cervical cancer up to two years earlier than conventional tests. LuViva is designed to provide an objective result at the point-of-care, thereby improving the management of cervical disease: www.guidedinc.com.

Company:

Guided Therapeutics, Inc.

 

 

Headquarters Address:

5835 Peachtree Corners East

 

Suite B

 

Norcross, GA 30092

 

 

Main Telephone:

770-242-8723

 

 

Website:

www.guidedinc.com

 

 

Ticker/ISIN:

GTHP(OTCQB)/US40171F1057

 

 

Type of Organization:

Public

 

 

Industry:

Medical Devices

 

 

Key Executives:

CEO: Gene Cartwright

 

COO: Mark Faupel

 

 

Investor Relations

 

Contact:

Mark Faupel

Phone:

770-242-8723

Email:

[email protected]

 

Copyright: 
Copyright Business Wire 2020